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Purpose
This first Korean prospective study is to evaluate the feasibility of prone breast radiotherapy
after breast conserving surgery for left breast cancer patients who have relatively small
breast size and we present dosimetric comparison between prone and supine positions. 
Materials and Methods
Fifty patients underwent two computed tomography (CT) simulations in supine and prone
positions. Whole breast, ipsilateral lung, heart, and left-anterior-descending coronary artery
were contoured on each simulation CT images. Tangential-fields treatment plan in each 
position was designed with total 50 Gy in 2-Gy fractions, and then one of the positions was
designated for the treatment by comparing target coverage and dose to normal organs.
Also, interfractional and intrafractional motion was evaluated using portal images. 
Results
In total 50 patients, 32 cases were decided as prone-position–beneficial group and 18
cases as supine-position–beneficial group based on dosimetric advantage. Target dose ho-
mogeneity was comparable, but target conformity in prone position was closer to optimal
than in supine position. For both group, prone position significantly increased lung volume.
However, heart volume was decreased by prone position for prone-position–beneficial group
but was comparable between two positions for supine-position–beneficial group. Lung and
heart doses were significantly decreased by prone position for prone-position–beneficial
group. However, prone position for supine-position–beneficial group increased heart dose
while decreasing lung dose. Prone position showed larger interfractional motion but smaller
intra-fractional motion than supine position. 
Conclusion
Prone breast radiotherapy could be beneficial to a subset of small breast patients since it
substantially spared normal organs while achieving adequate target coverage. 
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Introduction
Breast cancer is the most common cancer in women world-
wide [1] and the second most common cancer in Korean
women [2]. While postoperative whole breast radiotherapy
(RT) has previously been proven effective in clinical trials [3],
the concern about cardiac problems according to exposed
dose has been raised especially in left-sided breast cancer 
patients. Meta-analysis of U.S. breast cancer RT between 1973
and 2001 found an increase in heart-related mortality, when
older equipment and techniques had yet been utilized [4].
The reduction of heart perfusion according to RT volume
was also reported to be induced in 40% of patients within 
2 years [5]. In addition, we also see the coronary arteries
damaged by postoperative RT in left breast cancer patients
compared to the right [6]. A paper published in the New Eng-
land Journal of Medicine [7] reported that main coronary artery
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disease increased by 7.4% per 1 Gy of radiation exposure to
the heart (95% confidence interval, 2.9 to 14.5%), and there
was no threshold dose. Furthermore, this heart disease 
begins within 5 years after RT and appears to be continued
up to 30 years [7]. Even though recent paper [8] concluded
that study based on large population receiving whole breast
RT between 1990 and 1999 with median follow-up period of
15.5 years revealed no increase of cardiac-related mortality
to left breast cancer patients, cardiac dose is still important
consideration for whole breast RT. 
Besides heart, pulmonary toxicity is also one of the prob-
lems which cannot be ignored in long-term survivors who
received postoperative breast RT. Although the incidence of
clinical radiation pneumonitis after breast RT is not high, 
radiologic changes in lung due to the radiation have been 
observed in 20%-40% of the patients [9]. These radiation 
exposures have been reported to cause lung function deteri-
oration in long-term survivors [10]. Therefore, although the
incidence of pneumonia is low after RT, it is necessary to 
reduce the radiation dose to lungs to preserve pulmonary
function in long-term survivors. 
Breast cancer patients have received RT in supine position
with autonomic respiration, which is superior in terms of 
patient comfort and reproducibility. The above-mentioned
studies have also been conducted in supine position with 
autonomic respiration. There have been attempts to reduce
the radiation dose to the heart and lungs in postoperative
whole breast RT by applying prone or lateral decubitus 
positions and respiratory motion management [11-15]. Since
prone position was considered to be useful only in patients
with large volume of breast (> 1,000 mL), most of them were
studied mainly in United States and Europe. It was repeat-
edly shown that RT in prone position can reduce cardiac 
radiation exposure in left breast cancer [16-21]. Recently, it
has been reported that radiation dose to heart or lung is 
reduced by prone position for relatively smaller breast size
[22,23]. The results of this study gave the motivation that it
is possible to reduce radiation dose to heart and lungs by
means of the use of prone position even in Korean patients
whose average breast volume is much smaller. However, in
Korea, postoperative RT is performed in supine position for
most of the cases, and respiratory motion management RT
has been tried in some institutions [24].
Yet, the effectiveness of prone position in breast RT has not
been reported for Korean women with relatively small
breast. Hence, we proposed the first Korean prospective
phase II study to evaluate the feasibility of prone position in
the whole breast RT for Korean left breast cancer patients.
Materials and Methods
1. Patients
Fifty left breast cancer female patients receiving whole
breast irradiation after breast conserving surgery partici-
pated in this study and provided written informed consent
from December 2014 to June 2015. The inclusion criteria of
this study were as follows: age between 20 and 70 years with
pathologically confirmed left-sided breast cancer after cura-
tive resection and Eastern Cooperative Oncology Group per-
formance status 0 or 1. We excluded patient who needs the
irradiation of loco-regional lymph nodes area, who has com-
bined distant metastasis, who is pregnant or breast-feeding,
who has previous RT history of chest or neck area, or who is
not indicated postoperative whole breast RT. Based on the
results of previous clinical studies about prone breast RT, we
could hypothesize that the prone position can reduce 50% of
heart irradiation dose in 80% of left breast cancer patients
compared to the supine position. A total number of 50 pati-
ents were calculated to verify this hypothesize at an alpha of
0.05, a power of 80%, and dropout rate of 10%. 
2. Computed tomography simulations
Each patient underwent two computed tomography (CT)
simulations for whole breast irradiation: the first in supine
position and the second in prone position. First, CT images
were obtained in conventional supine and arm-up position
on a breast board (CIVCO Medical Solutions, Kalona, IA).
After that, second CT images were acquired in prone posi-
tion using a custom-made prone breast board made of
polyurethane foam with an aperture positioning left breast
and a wedge to set contralateral breast away from the RT
fields. Patient’s face was turned to the left to limit the rotation
of her body in prone position (Fig. 1). For both setups, radio-
opaque wires were placed to indicate palpable breast mass
and midline of chest of the patients. On the prone breast
board, radio-opaque markers were attached to point out the
position of aperture and the top of board in order to provide
accurate information for RT plan. Both CT images were 
obtained in 3.75-mm thick slices without contrast, and then
transferred to the treatment planning system, Pinnacle3
(Philips Healthcare, Fitchburg, WI).
3. RT planning and dosimetric comparison
The whole breast as a clinical target volume (CTV), ipsilat-
eral lung, heart, and left anterior descending coronary artery
(LADCA) were contoured on each CT images by a radiation
oncologist according to the Radiation Therapy Oncology
Group breast contouring atlas. Tangential-fields treatment
plan with 6-MV photons in each position was designed with
prescription dose of 50 Gy in 2 Gy fractions, and then the
dose-volume histograms for CTV and organs at risks were
compared between prone and supine positions. Primary end-
point was the irradiated cardiac dose (heart and LADCA),
and the secondary endpoints were the irradiated dose to 
ipsilateral lung and target coverage.
For target coverage, we compared the maximum and mean
dose (Dmax, Dmean), the dose received by at least 95% of the
CTV (D95), homogeneity index (HI) [25], and conformity
index (CI) [26]. The HI was calculated from the formula:
HI=(D2–D98)/Dp, where D98 is the dose received by at least
98% of the target volume, D2 is the dose received by at least
2% of the target volume, and Dp is the prescription dose to
the target volume. The D98 and D2 are considered to be the
minimum and maximum doses, respectively, and a lower HI
value indicates a more homogeneous dose administered to
the target volume. The CI was calculated from the formula:
CI=(TV95/TV)×(TV95/V95), where V95 is the target volume 
receiving 95% of the prescription dose, TV is the target vol-
ume, and V95 is the volume receiving 95% of the prescription
dose. The closer the CI is to 1 is indicative of optimal confor-
mation. For normal organs, we compared Dmax, Dmean, and the
percentage of the volume that receives more than 5, 10, 20,
30, 40, and 50 Gy (V5, V10, V20, V30, V40, and V50).
4. Treatment position designation
According to study protocol, the treatment position was
designated to deliver less radiation dose to the heart and
LADCA, considering the maximum dose and irradiated vol-
ume, while maintaining the appropriate dose (95%-107%) of
the prescribed dose to CTV. The LADCA dose was consid-
ered to be the determining factor of the highest priority. 
As a process of designation, we evaluated the parameters
between prone- and supine-position–beneficial groups for
each position. Age and chest and bust sizes, volumes of CTV,
heart, and LADCA in both prone and supine positions were
comparable between the two groups. Lung volume in prone
position for prone-position–beneficial group was smaller
than for supine-position–beneficial group (1,162.1±201.1 mL
vs. 1,296.4±224.7 mL, p=0.035), whereas lung volume in
supine position between the two groups was not statistically
different (1,081.4±213.7 mL vs. 1,197.1±232.7 mL, p=0.081).
Target dose parameters for each position were all compara-
ble between the two groups. Lung, heart, and LADCA dose
in prone position was significantly lower for prone-position–
beneficial group. In supine position, the lung dose was com-
parable between the two groups but heart and LADCA dose
was significantly lower for supine-position–beneficial group
than for prone-position–beneficial group.
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Fig. 1.  Prone breast board (A) and patient setup (B).
A
B
5. Treatment and verification
The treatment was performed using a Varian Clinac 6Ex
machine (Varian Medical Systems, Palo Alto, CA). For the
patient setup verification, a weekly portal image using an
electronic portal imaging device (EPID) was obtained. 
Intrafractional motion was assessed with images acquired at
a rate of two images per second using an EPID in cine mode
during one of the tangential beam delivery. To assess quan-
titatively, an external marker was placed on the left breast
tattoo during imaging time. The displacement of marker was
compared in portal images with that of the first fraction for
interfractional setup verification, and the maximum move-
ment of marker during beam delivery was analyzed in the
cine images for intrafractional motion.
6. Statistical analysis
Dosimetric parameters were examined by paired t test or
Wilcoxon signed-rank test. The correlation between dosimet-
ric benefit and treatment position were analyzed by paired 
t test or non-parametric statistical test including Kruskal-
Wallis test and Mann-Whitney U test. Inter-/intra-fractional 
motions of patients were evaluated by independent samples
t test. Statistical analyses were conducted using SPSS ver.
20.0.0 (IBM Corp., Armonk, NY). We considered a p-value
of less than 0.05 to be statistically significant.
7. Ethical statement
This prospective study received approval from internal 
eview boards of Samsung Medical Center (IRB No. 2014-06-
138-002) and performed in accordance with the principles of
the Declaration of Helsinki and Good Clinical Practice guide-
lines. All patients provided written informed consent before
enrollment in this study. The trial was registered at Clinical-
Trials.gov (NCT02231112).
Results
1. Total 50 enrolled patients
The characteristics of total 50 enrolled patients are listed
in Table 1. The median age of total 50 patients was 48 years
(range, 36 to 64 years). The median chest size was 78 cm
(range, 60 to 90 cm) and the median bust size was 88 cm
(range, 72 to 107 cm). The median breast, heart, and lung vol-
umes measured in supine position was 269.3 mL (range, 95.3
to 605.6 mL), 595.7 mL (range, 455.1 to 800.1 mL), and 1,137.9
mL (701.2-1,843.9 mL), respectively.
2. Dosimetric beneficial group
We performed the comparisons between prone and supine
positions for the entire patients and the comparisons of 
parameters are summarized in Table 2. Prone position sig-
nificantly increased the average volume of breast (CTV)
(304.8±149.3 mL vs. 285.0±126.5 mL, p=0.001). Ipsilateral lung
volume was also significantly increased while heart volume
was decreased in prone position (1,218.5±219.6 mL vs. 1,130±
227 mL, p < 0.001 and 590.9±85.7 mL vs. 614.0±91.7 mL, 
p < 0.001, respectively). The volume of LADCA was equiva-
lent in both positions. The radiation dose to the CTV was
similar when comparing Dmax and D95 of prone and supine
positions. The Dmean of CTV was statistically larger in prone
position but the absolute difference of the mean value bet-
ween two positions was only 0.3 Gy (50.8±0.4 Gy vs. 50.5±0.5
Gy, p < 0.001). The CI in prone position was closer to 1 indi-
cating more optimal target conformation (0.97±0.05 vs 0.86±
0.14, p < 0.001) while the HI was similar in both positions.
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Table 1. Characteristics of total 50 participants
Values are presented as median (range) or number (%).
a)Presented volumes are measured in supine position
which is a conventional setup for patients.
Characteristic No. (%)
Age (yr) 48 (36-64)
Type of breast cancer
Invasive ductal carcinoma 40 (80)
Ductal carcinoma in situ 3 (6)
Mixed invasive ductal carcinoma 3 (6)
Others 4 (8)
Surgery
Partial mastectomy 2 (4)
Partial mastectomy+ 48 (96)
sentinel lymph node dissection
Pathologic T category
Tis 3 (6)
T1 42 (84)
T2 5 (10)
Pathologic N category
N0 49 (98)
Nx 1 (2)
Chest size (cm) 78 (60-90)
Bust size (cm) 88 (72-107)
Breast volumea) (mL) 269.3 (95.3-605.6)
Heart volumea) (mL) 595.7 (455.1-800.1)
Lung volumea) (mL) 1,137.9 (701.2-1,843.9)
Yoonsun Chung, Prone Breast RT for Small Breast Patients
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Variable
Total patients (n=50)
Prone position Supine position p-value
Age (yr) 49±7
Chest size (cm) 78.4±6.3
Bust size (cm) 88.3±7.5
Volume (mL)
CTV (breast) 304.8±149.3 285.0±126.5 0.001
Lung 1,218.5±219.6 1,130.0±227.0 < 0.001
Heart 590.9±85.7 614.0±91.7 < 0.001
LADCA 0.9±0.2 0.9±0.2 0.039
Target dose
Dmax (Gy) 53.1±0.4 52.9±0.3 0.076
Dmean (Gy) 50.8±0.4 50.5±0.5 < 0.001
D95 (Gy) 48.9±0.6 48.7±0.7 0.053
HI 0.09±0.02 0.10±0.10 0.463
CI 0.97±0.05 0.86±0.14 < 0.001
Dose in OAR
Lung
Dmax (Gy) 38.8±14.6 50.8±1.2 < 0.001
Dmean (Gy) 1.4±1.0 7.5±1.8 < 0.001
V5 (%) 3.4±3.4 23.2±4.5 < 0.001
V10 (%) 2.2±2.5 17.7±4.3 < 0.001
V20 (%) 1.5±1.9 14.0±4.1 < 0.001
V30 (%) 1.1±1.6 11.8±4.0 < 0.001
V40 (%) 0.7±1.2 8.8±3.6 < 0.001
V50 (%) 0±0 0.2±0.4 < 0.001
Heart
Dmax (Gy) 42.6±9.7 48.2±6.8 0.002
Dmean (Gy) 2.4±1.2 3.4±3.6 0.063
V5 (%) 5.1±3.6 6.8±3.5 0.015
V10 (%) 3.3±2.9 4.7±2.9 0.014
V20 (%) 2.4±2.5 3.6±2.4 0.017
V30 (%) 1.9±2.2 2.9±2.1 0.019
V40 (%) 1.3±1.8 2.2±1.8 0.019
V50 (%) 0±0 0.1±0.2 0.005
LADCA
Dmax (Gy) 30.9±15.8 41.8±12.7 < 0.001
Dmean (Gy) 5.6±3.8 10.0±5.8 < 0.001
V5 (%) 17.7±9.1 28.8±13.1 < 0.001
V10 (%) 10.5±9.2 22.0±13.1 < 0.001
V20 (%) 8.0±8.9 18.2±13.0 < 0.001
V30 (%) 6.4±8.1 15.9±12.5 < 0.001
V40 (%) 5.0±7.6 12.8±11.5 < 0.001
V50 (%) 0±0 0.6±2.8 0.147
Values are presented as mean±standard deviation. CTV, clinical target volume; LADCA, left anterior descending coronary
artery; Dmax, maximum dose; Dmean, mean dose; D95, dose received by at least 95% of the clinical target volume; HI, homo-
geneity index; CI, conformity index; OAR, organs at risk; VX, percentage of the volume that receives more than X Gy.
Table 2. Comparison between prone and supine positions for total 50 patients
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Prone-position–beneficial group (n=32)                     Supine-position–beneficial group(n=18)
Variable Prone Supine  
p-value
Prone Supine 
p-value
position position position position
Age (yr) 48±8 49±8
Chest size (cm) 77.9±6.1 79.2±6.8
Bust size (cm) 87.6±6.9 89.6±8.5
Volume (mL)
CTV (Breast) 291.6±122.2 284.9±119.5 0.102 323.0±182.0 285.1±138.6 0.004
Lung 1,162.1±201.1 1,081.4±213.7 < 0.001 1,296.4±224.7 1,197.1±232.7 0.002
Heart 591.7±87.9 624.6±96.5 < 0.001 589.6±84.7 599.3±84.6 0.200
LADCA 1.0±0.2 0.9±0.2 0.056 0.9±0.2 0.9±0.2 0.451
Target dose
Dmax (Gy) 53.1±0.5 52.9±0.3 0.019 53.0±0.3 53.0±0.3 0.732
Dmean (Gy) 50.8±0.4 50.5±0.4 0.001 50.8±0.3 50.5±0.5 0.083
D95 (Gy) 49.0±0.6 48.7±0.6 0.099 48.8±0.6 48.6±0.8 0.323
HI 0.08±0.02 0.10±0.13 0.379 0.09±0.02 0.08±0.02 0.219
CI 0.99±0.02 0.85±0.14 < 0.001 0.96±0.07 0.86±0.15 0.002
Dose in OAR
Lung
Dmax (Gy) 34.9±16 51.0±1.1 < 0.001 44.2±10.4 50.5±1.2 0.023
Dmean (Gy) 0.9±0.6 7.6±2.0 < 0.001 1.9±1.2 7.4±1.6 < 0.001
V5 (%) 2.0±2.1 23.1±4.9 < 0.001 5.2±4 23.4±4.0 < 0.001
V10 (%) 1.2±1.4 17.7±4.6 < 0.001 3.5±2.9 17.5±3.9 < 0.001
V20 (%) 0.7±1 14.2±4.4 < 0.001 2.6±2.3 13.7±3.7 < 0.001
V30 (%) 0.5±0.8 12.0±4.2 < 0.001 2.0±1.9 11.4±3.6 < 0.001
V40 (%) 0.3±0.5 9.2±3.9 < 0.001 1.4±1.5 8.3±3.2 < 0.001
V50 (%) 0±0 0.3±0.5 0.002 0±0 0.1±0.2 0.019
Heart
Dmax (Gy) 40.6±10.5 49.8±1.2 < 0.001 45.4±7.7 45.9±10.1 0.957
Dmean (Gy) 2.0±0.8 4.2±4.6 0.016 2.9±1.5 2.4±1.0 0.016
V5 (%) 4.0±2.6 8.1±3.2 < 0.001 6.5±4.4 4.9±3.1 0.014
V10 (%) 2.5±2 5.9±2.7 < 0.001 4.5±3.6 3.2±2.3 0.022
V20 (%) 1.7±1.6 4.6±2.4 < 0.001 3.4±3.2 2.3±1.9 0.023
V30 (%) 1.3±1.3 3.7±2.2 < 0.001 2.7±2.8 1.8±1.5 0.027
V40 (%) 0.8±1 2.8±1.9 < 0.001 2.0±2.3 1.3±1.2 0.038
V50 (%) 0±0 0.1±0.2 0.017 0±0 0±0.1 0.083
LADCA
Dmax (Gy) 29.3±14.6 47.2±5.6 < 0.001 33.0±17.5 34.2±15.8 0.349
Dmean (Gy) 4.6±2.6 12.8±5.5 < 0.001 7.0±4.7 6.3±3.8 0.099
V5 (%) 16.5±7.4 33.6±13.3 < 0.001 19.4±10.9 22.1±9.8 0.588
V10 (%) 8.4±7.1 27.9±12.4 < 0.001 13.4±11 14±9.3 0.302
V20 (%) 5.8±6.8 24.3±12.1 < 0.001 11.1±10.7 9.9±9.2 0.037
V30 (%) 4.3±6.1 21.7±11.5 < 0.001 9.3±9.8 7.7±8.9 0.013
V40 (%) 2.9±5 17.9±11.3 < 0.001 7.9±9.5 5.9±7.4 0.008
V50 (%) 0±0 1±3.7 0.154 0±0 0±0.1 0.331
Values are presented as mean±standard deviation. CTV, clinical target volume; LADCA, left anterior descending coronary
artery; Dmax, maximum dose; Dmean, mean dose; D95, dose received by at least 95% of the clinical target volume; HI, homo-
geneity index; CI, conformity index; OAR, organs at risk; VX, percentage of the volume that receives more than X Gy.
Table 3. Comparison between prone and supine positions for prone- and supine-position–beneficial groups
All dose values (Dmax, Dmean, and V5-V50) of ipsilateral lung,
heart, and LADCA were lower in prone position than in
supine position (Table 2). 
Among these 50 patients, 32 cases were decided as prone-
position–beneficial group and 18 cases as supine-position–
beneficial group in terms of dosimetric advantage after the
dosimetric results of treatment plans for both setups were
thoroughly compared according to study protocol. The com-
parisons between prone and supine positions for each prone-
and supine-position–beneficial group are described in Table
3. Age, chest size, and bust size between prone-position–ben-
eficial and supine-position–beneficial groups were compara-
ble (p=0.723, p=0.356, and p=0.550, respectively). For prone-
position–beneficial group, prone position significantly 
increased lung volume (1,162.1±201.1 mL vs. 1,081.4±213.7
mL, p < 0.001) but decreased heart volume (591.7±87.9 mL
vs. 624.6±96.5 mL, p < 0.001), while CTV was not statistically
different between the two positions. In contrast, for supine-
position–beneficial group, prone position also increased lung
volume (1,296.4±224.7 mL vs. 1,197.1±232.7 mL, p=0.002) as
well as CTV (323.0±182.0 mL vs. 285.1±138.6 mL, p=0.004),
but heart volume was comparable between two setups
(589.6±84.7 mL vs. 599.3±84.6 mL, p=0.200). LADCA volume
was comparable between the two setups for both groups.
3. Target coverage
Target coverage dose was comparable between two setups
for supine-position–beneficial group in terms of Dmax, Dmean,
and D95. Target dose (Dmax and Dmean) was higher in prone 
position than in supine position for prone-position–beneficial
group, but the absolute differences of those values were very
minimal (Table 3). For both groups, HI was comparable 
between prone and supine positions, but CI was more optimal
in prone position than in supine position (prone-position–
beneficial group, 0.99±0.02 vs. 0.85±0.14, p < 0.001; supine-
position–beneficial group, 0.96±0.07 vs. 0.86±0.15, p=0.002)
(Table 3).
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Fig. 2.  Dosimetric comparison of organs at risk between supine and prone positioning with isodose lines and dose volume
histogram for a case with chest size of 84 cm and breast volume in prone position of 302 mL (A) and a case with chest size
of 68 cm and breast volume in prone position of 462 mL (B). The lung (blue), heart (red), and left anterior descending coronary
artery (LADCA, green) are delineated as organs at risk. CTV, clinical target volume.
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4. Normal organ sparing
Lung dose (Dmax, Dmean, and V5-V50) was substantially 
decreased in prone position than in supine position for both
prone and supine-position–beneficial groups, along with the
fact that absolute dose differences were considerably larger
in prone-position–beneficial group than in supine-position–
beneficial group (Table 3). Prone position for prone-position–
beneficial group significantly decreased the dose to heart and
LADCA (Dmax, Dmean, and V5-V50). On the other hand, prone
position for supine-position–beneficial group significantly 
increased the heart dose (Dmean and V5-V50) (Table 3). For
supine-position–beneficial group, prone position increased
V20, V30, and V40 of LADCA considerably, while Dmax, Dmean,
V5, V10, and V50 of LADCA were similar (Table 3). Fig. 2
showed dosimetric comparison of normal organs between
supine and prone position with isodose lines and dose vol-
ume histo-gram for a case with chest size of 84 cm and breast
volume in prone position of 302 mL (Fig. 2A) and a case with
chest size of 68 cm and breast volume in prone position of
462 mL (Fig. 2B). 
5. Patient motion
Comparisons of inter- and intra-fractional motions bet-
ween patients treated in supine and prone positions are 
depicted in Fig. 3. For interfractional movement, a total of
116 EPID images of prone position treatments and 74 images
of supine position treatments were reviewed. The average of
setup variation was 3.57±3.56 mm in superior-inferior (SI) 
direction and 2.61±2.02 mm in anterior-posterior (AP) direc-
tion for prone position treatment and 1.35±1.05 mm in SI 
direction and 1.46±1.14 mm in AP direction for supine posi-
tion treatment. Intrafractional motion was assessed by
0.19±0.13 mm in SI direction and 0.48±0.32 mm in AP direc-
tion from 140 EPID cine images of prone position treatment
and 0.72±0.40 mm in SI direction and 0.86±0.49 mm in AP 
direction from 99 EPID images of supine position treatment.
Interfractional setup variation was larger in prone position
treatment (p < 0.001 for both SI and AP direction), whereas
motion during treatment was lager in supine position treat-
ment (p < 0.001 for both SI and AP direction).
Discussion
To save the heart for left breast cancer patients, several
techniques that displace the heart from the irradiation field
have been utilized, which include respiratory motion man-
agement (breath hold) or patient positioning in prone or lat-
eral decubitus. Breath-hold technique usually requires more
than twice as much treatment time as conventional RT, and
patients must control their own breathing, which is not fea-
sible in elderly patients or those with poor performance sta-
tus [14]. In case of lateral decubitus position, due to relatively
unstable posture, the reproducibility, which is one of the
most important challenges in RT, may be seriously degraded.
Even though the prone position may also be discomfort dur-
ing the treatment compared to the supine position, it is more
advantageous than the two methods mentioned above [13].
Prone breast RT has been known as effective for patients
with large pendulous breast, such as breast volume larger
than 750 mL or 1,000 mL [19,20]. As Asian women usually
have a smaller breast size, prone position was considered not
having dosimetric advantage to Asian breast cancer patients.
There were studies about the breast size, but they have not
invol-ved such small breasts [22] or prone position did not
reduce in-field heart volume statistically significantly in
women with breast size smaller than 750 mL [17]. Even in
Asian studies, patients with relatively large breast size were
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Fig. 3.  Comparison of inter- (A) and intra-fractional (B) motion between patients treated in supine and prone positions. Ant-
Post, anterior-posterior; Sup-Inf, superior-inferior.
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evaluated for prone positioning [23,27]. However, this pro-
spective study enrolled by 50 patients with mean breast size
of 305 mL (in prone position) revealed that such small breast
size could also gain dosimetric benefit on heart and lung by
prone position while sustaining or even improving target
coverage. 
CTV breast volume of total 50 participants ranged 94.2 to
786.5 mL (median, 294.1 mL) in prone position and 95.3 to
605.6 mL (median, 269.3 mL) in supine position. Prone posi-
tion significantly increased the average CTV volume (304.8±
149.3 mL vs. 285.0±126.5 mL, p=0.001) in total patients, but
the average CTV volume was comparable between prone
and supine-position–beneficial groups (prone 291.6±122.2
mL vs. supine 323.0±182.0 mL, p=0.470). Prone-position–ben-
eficial group had CTV volume in prone position ranging
from 103.2 to 638.4 mL. Prone position increased the volume
of ipsilateral lung, and the relative lung volume change by
prone position was similar between prone and supine-posi-
tion–beneficial groups. Yet, the heart volume decreased in
prone position for total patients, but the relative heart vol-
ume change by prone position was greater in prone-position–
beneficial group than in supine-position–beneficial group
(but not statistically significant). However, we could not find
the relationship between dosimetric gain and patient char-
acteristics (breast or chest size) or volume change by prone
positioning. The certain optimal subgroup having definite
benefit by prone position was difficult to find probably due
to a small number of participant in this Phase II study and
small range of patients’ breast size. Nevertheless, we could
find dosimetric advantage in prone breast RT for patients
having such small breast size even around 100 ml. A further
study with a larger number of patients will be needed to find
the ideal patient group who will have definite dosimetric
gain. This further study will allow us to identify the patient
for prone breast RT without two CT simulations for the com-
parison between supine and prone positions so as to avoid 
unnecessary radiation exposure to the patient.
Similar to earlier studies about prone breast RT [28,29], our
study also found that the treatment in prone position showed
larger interfractional motion but smaller intrafractional 
motion than the treatment in supine position. The patient's
breathing was restricted due to the compression of the chest
wall by lying on the prone breast board, so the intrafractional
motion was limited than the supine position. However, there
is no correlation between patient characteristics and the inter-
or intra-fractional motion. Among 32 patients having dosi-
metric benefit in prone position, three patients showed 
extremely unstable setup during the process for the localiza-
tion of treatment center before starting treatment, so physi-
cians reviewed their treatment plans whether there was a
critical clinical decision point and decided to treat them in
supine position. Due to the lack of resource in our institution,
we could utilize only EPID not cone-beam CT for these treat-
ments. So, we were able to check the patient setup in SI and
AP directions but not in lateral direction. The lateral setup of
the patient was confirmed by localizing laser and patient tat-
too and by checking the position of a marker atta-ched to the
midline of the patient. We found that a few patients treated
in prone position, who enrolled in early-phase of this study,
experienced contralateral breast exposure, especially with
collimator rotation in the treatment parameter. So, we che-
cked whether radiation fields extended to the contralateral
breast with Gafchromic EBT3 film placed under the con-
tralateral breast of the patient in the first few sessions of treat-
ment. Also, we tried not to rotate the collimator in the treat-
ment plan for prone position. With these efforts, the con-
tralateral breast exposure problem was resolved.
In conclusion, prone breast RT could be beneficial to a sub-
set of small breast patients since it substantially spared nor-
mal organs while achieving adequate coverage of breast
tissue. We observed patient-specific and considerable inter-
fractional setup error, but it was not the extent to negatively
affect treatment quality of whole breast irradiation. Further
prospective study is required to validate the potential benefit
and the optimal patient group with prone breast RT.
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